Lynx1 Capital Management LP
CIK
1910456
Location
DORADO, PR
Portfolio Value
Small
$632,594,991
Diversification
Moderately concentrated
Filing Date
Global Rank
#2,300
/ 8,605
▲ 380
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+44.0%
Period ended 3 months ago
Filed May 18, 2026 · 52d
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+368.5%
SPY
+76.5%
Annualised alpha
+46.5%
Max drawdown
−65.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
22 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
24.5%
−10.2 pts
Top 5
88.2%
−0.6 pts
Top 10
97.1%
−0.1 pts
HHI
1,827
Moderately concentrated−506
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $632,594,991 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals, Inc. | +2,531,944 | 2,611,568 | $88,349,345 | |
| KRRO | Korro Bio, Inc. | +860,381 | 1,538,296 | $17,413,510 | |
| GHRS | GH Research PLC | +356,713 | 10,763,288 | $151,331,829 | |
| TRDA | Entrada Therapeutics, Inc. | +160,000 | 211,689 | $2,671,515 | |
| DNLI | Denali Therapeutics Inc. | +141,553 | 1,880,303 | $36,101,817 | |
| DSGN | Design Therapeutics, Inc. | +50,000 | 119,516 | $1,271,650 | |
| HOWL | Werewolf Therapeutics, Inc. | +1,860 | 657,786 | $547,935 | |
| NEUP | Neuphoria Therapeutics Inc. | +100 | 875,328 | $3,562,584 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IMTX | Immatics N.V. | −704,977 | 216,973 | $2,135,014 | |
| STOK | Stoke Therapeutics, Inc. | −641,001 | 4,763,673 | $155,105,192 | |
| XNCR | Xencor Inc | −169,160 | 536,398 | $6,468,959 | |
| CCCC | C4 Therapeutics, Inc. | −99,231 | 6,998,902 | $18,407,112 | |
| DTIL | Precision Biosciences Inc | −8,800 | 985,113 | $5,418,121 | |
| No positions match the current search. | |||||
22 positions ·
$632,594,991 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 4,763,673 | $155,105,192 | 24.52% | |
| GHRS |
GH Research PLC
Healthcare
|
Added | 10,763,288 | $151,331,829 | 23.92% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 8,963,500 | $127,371,335 | 20.13% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 2,611,568 | $88,349,345 | 13.97% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 1,880,303 | $36,101,817 | 5.71% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
Reduced | 6,998,902 | $18,407,112 | 2.91% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Added | 1,538,296 | $17,413,510 | 2.75% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
Held | 8,019,148 | $8,099,339 | 1.28% | |
| XNCR |
Xencor Inc
Healthcare
|
Reduced | 536,398 | $6,468,959 | 1.02% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
Reduced | 985,113 | $5,418,121 | 0.86% | |
| PASG |
Passage BIO, Inc.
Healthcare
|
Held | 623,704 | $4,896,076 | 0.77% | |
| NEUP |
Neuphoria Therapeutics Inc.
Healthcare
|
Added | 875,328 | $3,562,584 | 0.56% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
Added | 211,689 | $2,671,515 | 0.42% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Held | 31,591 | $2,138,078 | 0.34% | |
| IMTX |
Immatics N.V.
Healthcare
|
Reduced | 216,973 | $2,135,014 | 0.34% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Added | 119,516 | $1,271,650 | 0.20% | |
| VYNE |
VYNE Therapeutics Inc.
Healthcare
|
NEW | 1,628,700 | $973,962 | 0.15% | |
| HOWL |
Werewolf Therapeutics, Inc.
Healthcare
|
Added | 657,786 | $547,935 | 0.09% | |
| IBIO |
iBio, Inc.
Healthcare
|
NEW | 68,076 | $129,344 | 0.02% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 68,486 | $110,947 | 0.02% | |
| ABSI |
Absci Corp
Healthcare
|
NEW | 21,245 | $63,735 | 0.01% | |
| TRAW |
Traws Pharma, Inc.
Healthcare
|
NEW | 15,078 | $27,592 | 0.00% |